Evotec SE Set to Reveal Q1 2024 Results on May 22, 2024 - What to Expect?

• Evotec SE will announce its financial results for the first quarter of 2024 on 22 May 2024.
• The company will hold a conference call to discuss the results and provide an update on its performance.
• The conference call will be held in English and will be available via audio webcast.
• Evotec is a life science company that provides high value pipeline co-creating partnerships and solutions to all Top 20 Pharma and over 800 biotechnology companies.
• The company operates globally with more than 5,000 highly qualified people and has a portfolio of more than 200 proprietary and co-owned R&D projects.
• Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including neurology, oncology, metabolic and infectious diseases.

The next important date, BofA Healthcare Conference, at Evotec is on 15.05.2024.

The price of Evotec at the time of the news was 10,460EUR and was up +2,40 % compared with the previous day.
At this time, the index MDAX was at 27.304,02PKT (+0,17 %).

Evotec

-0,39 %

-6,65 %

-4,03 %

-36,55 %

-55,39 %

-74,33 %

-60,91 %

+152,51 %

+261,65 %

ISIN:DE0005664809WKN:566480

• Intraday
• 5 Tage
• 1 Monat
• 3M
• 1 Jahr
• 3J
• 5J
• 10J
• Max